Editorial: Hepatic immune response underlying liver cirrhosis and portal hypertension

被引：0
|
作者：
Guo, Yangkun [1 ]
Ma, Xiong [2 ]
Nie, Yongzhan [3 ,4 ]
Kostallari, Enis [5 ]
Gao, Jinhang [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, Chengdu, Peoples R China
[2] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Inst Digest Dis, Sch Med,Div Gastroenterol & Hepatol,Natl Hlth Comm, Shanghai, Peoples R China
[3] Air Force Mil Med Univ, Natl Clin Res Ctr Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China
[4] Air Force Mil Med Univ, Xijing Hosp Digest Dis, Xian, Peoples R China
[5] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
来源：
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词：
liver cells; immune response; liver fibrosis; portal hypertension; gut-liver axis; MACROPHAGES; ORIGIN; CELLS; AXIS;
D O I：
10.3389/fimmu.2023.1174562
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Portal hypertension reversibility with treatment of underlying liver disease
    Kwo P.Y.
    Lacerdo M.A.
    Current Hepatology Reports, 2015, 14 (3) : 219 - 224
  • [22] Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments
    Herath, Chandana B.
    Angus, Peter W.
    Trebicka, Jonel
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [23] The role of endoscopic ultrasound for portal hypertension in liver cirrhosis
    Cosmas Rinaldi Adithya Lesmana
    Maria Satya Paramitha
    Rino A. Gani
    Laurentius A. Lesmana
    Journal of Medical Ultrasonics, 2022, 49 : 359 - 370
  • [24] The role of endoscopic ultrasound for portal hypertension in liver cirrhosis
    Lesmana, Cosmas Rinaldi Adithya
    Paramitha, Maria Satya
    Gani, Rino A.
    Lesmana, Laurentius A.
    JOURNAL OF MEDICAL ULTRASONICS, 2022, 49 (03) : 359 - 370
  • [25] Possible Treatment Strategies for Portal Hypertension in Liver Cirrhosis
    Robert Schierwagen
    Frank Erhard Uschner
    Sabine Klein
    Jonel Trebicka
    Current Hepatology Reports, 2016, 15 (4) : 271 - 279
  • [26] Aspects of pathogenetc pharmacotherapy for portal hypertension in liver cirrhosis
    Garbuzenko, D. V.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (02) : 101 - 108
  • [27] Elastography in the diagnosis of portal hypertension in patients with liver cirrhosis
    Liusina, E. O.
    Pavlov, Ch. S.
    Ivashkin, V. T.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (02) : 33 - 37
  • [28] Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study
    Kim, Moon Young
    Baik, Soon Koo
    Park, Dong Hun
    Lim, Dae Wook
    Kim, Jae Woo
    Kim, Hyun Soo
    Kwon, Sang Ok
    Kim, Young Ju
    Chang, Sei Jin
    Lee, Samuel S.
    LIVER INTERNATIONAL, 2007, 27 (08) : 1103 - 1110
  • [29] Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis
    Fortea, Jose I.
    Zipprich, Alexander
    Fernandez-Mena, Carolina
    Puerto, Marta
    Bosoi, Cristina R.
    Almagro, Jorge
    Hollenbach, Marcus
    Banares, Juan
    Rodriguez-Sanchez, Belen
    Cercenado, Emilia
    Clement, Marc-Andre
    Rose, Christopher F.
    Banares, Rafael
    Vaquero, Javier
    Ripoll, Cristina
    LIVER INTERNATIONAL, 2018, 38 (01) : 102 - 112
  • [30] Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol
    Wang, Lei
    He, Fu-Liang
    Liu, Fu-Quan
    Yue, Zhen-Dong
    Zhao, Hong-Wei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (32) : 9544 - 9553
12345